Beyondspring Stock Today
| BYSI Stock | USD 2.18 0.02 0.91% |
PerformanceOK
| Odds Of DistressVery Low
|
BeyondSpring is trading at 2.18 as of the 20th of July 2025. This is a 0.91 percent decrease since the beginning of the trading day. The stock's open price was 2.2. BeyondSpring has under 5 % chance of experiencing financial distress over the next 2 years and had a ok performance during the last 90 days. The performance scores are derived for the period starting the 21st of April 2025 and ending today, the 20th of July 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 9th of March 2017 | Category Healthcare | Classification Health Care |
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company was founded in 2010 and is headquartered in New York, New York. Beyondspring operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 40.32 M outstanding shares of which 2.12 M shares are currently shorted by private and institutional investors with about 42.87 trading days to cover. More on BeyondSpring
Moving together with BeyondSpring Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
BeyondSpring Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Thematic Idea | Cancer Fighters (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBeyondSpring can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand BeyondSpring's financial leverage. It provides some insight into what part of BeyondSpring's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BeyondSpring (BYSI) is traded on NASDAQ Exchange in USA. It is located in 100 Campus Drive, Florham Park, NJ, United States, 07932 and employs 40 people. BeyondSpring is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 87.89 M. BeyondSpring conducts business under Biotechnology sector and is part of Health Care industry. The entity has 40.32 M outstanding shares of which 2.12 M shares are currently shorted by private and institutional investors with about 42.87 trading days to cover.
BeyondSpring currently holds about 72.37 M in cash with (16.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.86.
Check BeyondSpring Probability Of Bankruptcy
Ownership AllocationBeyondSpring holds a total of 40.32 Million outstanding shares. BeyondSpring shows 15.26 percent of its outstanding shares held by insiders and 13.1 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BeyondSpring Ownership Details
BeyondSpring Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Trifecta Capital Advisors Llc | 2025-03-31 | 1.5 K | |
| Steward Partners Investment Advisory, Llc | 2025-03-31 | 1.1 K | |
| Jpmorgan Chase & Co | 2025-03-31 | 600 | |
| Sbi Securities Co Ltd | 2025-03-31 | 87.0 | |
| Banque Transatlantique | 2025-03-31 | 70.0 | |
| Simplex Trading, Llc | 2024-12-31 | 9.0 | |
| Barclays Plc | 2025-03-31 | 4.0 | |
| Wells Fargo & Co | 2025-03-31 | 0.0 | |
| Citigroup Inc | 2024-12-31 | 0.0 | |
| Decheng Capital Llc | 2025-03-31 | 4.9 M | |
| Blackrock Inc | 2025-03-31 | 219.9 K |
BeyondSpring Historical Income Statement
BeyondSpring Stock Against Markets
BeyondSpring Corporate Management
| Kenneth Lloyd | Chief Officer | Profile | |
| Gregg Russo | Senior Resources | Profile | |
| Stephen Kilmer | Head Relations | Profile | |
| June Lu | Chief Officer | Profile | |
| Linqing Jia | CoFounder | Profile | |
| Ramon Mohanlal | Chief RD | Profile | |
| Lan Huang | Chairman CoFounder | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeyondSpring. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in BeyondSpring Stock please use our How to Invest in BeyondSpring guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeyondSpring. If investors know BeyondSpring will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeyondSpring listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.22) | Revenue Per Share | Quarterly Revenue Growth 0.143 | Return On Assets | Return On Equity |
The market value of BeyondSpring is measured differently than its book value, which is the value of BeyondSpring that is recorded on the company's balance sheet. Investors also form their own opinion of BeyondSpring's value that differs from its market value or its book value, called intrinsic value, which is BeyondSpring's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeyondSpring's market value can be influenced by many factors that don't directly affect BeyondSpring's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeyondSpring's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeyondSpring is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeyondSpring's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.